Republic Act 9711

1. Definition

Republic Act 9711 (RA 9711), officially designated as the Food and Drug Administration (FDA) Act of 2009, is a Philippine law that reformed and strengthened the regulatory capacity of the country’s food and drug administration. Enacted to protect public health, the law converted the older BFAD into the modern FDA Philippines, expanded its enforcement powers, authorized the establishment of regional testing laboratories, and set strict registration, safety, and labeling protocols for foods, drugs, cosmetics, and Dietary Supplements. ([Official Gazette][1])

2. Alternate Names

*   Republic Act 9711
*   RA 9711
*   FDA Act of 2009
*   Food and Drug Administration Act

3. Recognized Identities

*   Wikipedia: Food and Drug Administration (Philippines)
*   Wikidata: Q5465377
*   DBpedia: Food_and_Drug_Administration_(Philippines)
*   ProductOntology: N/A
*   Wiktionary: N/A
*   Library of Congress Subject Headings (LCSH): Drugs — Law and legislation — Philippines
*   MeSH: N/A
*   NCBI Taxonomy: N/A
*   AGROVOC: N/A
*   Google Scholar: Republic Act 9711 FDA Act of 2009 health product registration enforcement
*   ConceptNet: N/A
*   OpenCyc: N/A

4. Examples of Usage

*   **FDA Enforcement Action:** The closure of a warehouse distributing unregistered health supplements under the authority of RA 9711.
*   **Dietary Supplement Regulation in the Philippines:** The main canonical article details the licensing, registration, and product labeling regulations established under RA 9711.

5. Typical Scenarios

*   **Registering an herbal remedy:** A health manufacturer submits laboratory stability reports and pays fee deposits to secure an FDA CPR under RA 9711 regulations.
*   **Filing a complaint on adulterated food:** A consumer files an official complaint to the FDA after discovering hazardous chemical contamination in a commercial food brand.

6. Key Strategies

*   Cross-reference health registration procedures with the main Dietary Supplement Regulation in the Philippines article.
*   Consult the FDA verification portal to confirm if a product's CPR is active under RA 9711 rules before buying.

7. Safety & Security Measures

*   Ensure all marketed products feature the correct registration number on their packaging to avoid seizure under RA 9711.
*   Confirm that dietary supplement labels carry the mandatory FDA warning phrase: 'No Approved Therapeutic Claims'.

8. Historical Context

RA 9711 was signed on August 18, 2009 by President Gloria Macapagal-Arroyo to resolve long-standing regulatory backlogs. By converting the BFAD into a decentralized administration with police and seizure powers, the law allowed the FDA to effectively target the growing trade of counterfeit medicines and unregistered health supplements entering the country. ([Official Gazette][1])

9. Common Challenges

*   **Counterfeit Supplement Trade:** The rapid growth of e-commerce platforms makes it difficult for FDA inspectors to halt the distribution of unregistered health capsules.
*   **Regulatory Backlogs:** Evaluating thousands of medical device and drug applications with limited laboratory staff causes approval delays for local manufacturers.

10. Related Topics

*   [[Dietary Supplement Regulation in the Philippines]]
*   [[FDA Philippines]]
*   [[DMI Medical Supply Co., Inc.]]
*   [[MX3 Capsule]]

11. References

1.  [Official Gazette of the Republic of the Philippines](http://www.officialgazette.gov.ph/)